TW354256B - A pharmaceutical composition for oral consumption in aqueous solution comprising a drug/<beta>-cyclodextrin complex and a pharmaceutically acceptable acid-base couple - Google Patents
A pharmaceutical composition for oral consumption in aqueous solution comprising a drug/<beta>-cyclodextrin complex and a pharmaceutically acceptable acid-base coupleInfo
- Publication number
- TW354256B TW354256B TW083107332A TW83107332A TW354256B TW 354256 B TW354256 B TW 354256B TW 083107332 A TW083107332 A TW 083107332A TW 83107332 A TW83107332 A TW 83107332A TW 354256 B TW354256 B TW 354256B
- Authority
- TW
- Taiwan
- Prior art keywords
- drug
- beta
- pharmaceutically acceptable
- aqueous solution
- cyclodextrin complex
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939316580A GB9316580D0 (en) | 1993-08-10 | 1993-08-10 | Pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW354256B true TW354256B (en) | 1999-03-11 |
Family
ID=10740244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW083107332A TW354256B (en) | 1993-08-10 | 1994-08-11 | A pharmaceutical composition for oral consumption in aqueous solution comprising a drug/<beta>-cyclodextrin complex and a pharmaceutically acceptable acid-base couple |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0720476A1 (zh) |
| JP (1) | JPH09501421A (zh) |
| CN (1) | CN1112180C (zh) |
| AU (1) | AU688789B2 (zh) |
| CA (1) | CA2169159C (zh) |
| GB (1) | GB9316580D0 (zh) |
| TW (1) | TW354256B (zh) |
| WO (1) | WO1995004528A2 (zh) |
| ZA (1) | ZA945930B (zh) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA959469B (en) * | 1994-11-15 | 1996-05-15 | South African Druggists Ltd | Pharmaceutical composition |
| ES2171110B1 (es) * | 2000-03-03 | 2003-06-16 | Aplicaciones Farmacodinamicas | Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion. |
| ES2189682B1 (es) * | 2001-12-11 | 2004-04-01 | Laboratorios Del Dr. Esteve, S.A. | Preparacion bebible que comprende ketoprofeno y su empleo en el tratamiento de procesos que cursan con fiebre, inflamacion y/o dolor, en un colectivo de animales, de forma simultanea. |
| CZ295151B6 (cs) * | 2004-02-20 | 2005-06-15 | I. Q. A., A. S. | Stabilní, chuťově přijatelné sirupy obsahující ibuprofen a způsob jejich přípravy |
| DE602007010254D1 (de) * | 2006-03-16 | 2010-12-16 | Novartis Ag | Feste dosierungsform mit einem wirkstoff mit unterdrücktem geschmack |
| KR20170123724A (ko) | 2006-03-28 | 2017-11-08 | 자블린 파머슈티칼스 인코포레이티드 | 저 투여량의 디클로페낙 및 베타-사이클로덱스트린 제형 |
| LT2253329T (lt) * | 2009-04-27 | 2017-02-27 | Laboratorio De Aplicaciones Farmacodinamicas, S.A. | Ibuprofeno lizinato peroralinė suspensija |
| TW201038296A (en) * | 2009-04-27 | 2010-11-01 | Aplicaciones Farmacodinamicas S A Lab De | Ibuprofen lysinate oral suspension |
| JP5853430B2 (ja) * | 2010-06-21 | 2016-02-09 | 大正製薬株式会社 | 内服液剤 |
| CN101987089B (zh) * | 2010-11-10 | 2012-07-04 | 天大药业（珠海）有限公司 | 泡腾药物制剂 |
| GB201021267D0 (en) * | 2010-12-15 | 2011-01-26 | Reckitt Benckiser Healthcare Int Ltd | Novel pharmaceutical formulation |
| NZ702930A (en) * | 2012-06-28 | 2017-05-26 | Mcneil-Ppc Inc | Racecadotril liquid compositions |
| US9114171B2 (en) * | 2012-06-28 | 2015-08-25 | Mcneil-Ppc, Inc. | Racecadotril liquid compositions |
| BR112015005968A2 (pt) * | 2012-09-18 | 2017-07-04 | Mcneil Ppc Inc | formas de dosagem orais de liberação prolongada compreendendo partículas derivadas do ácido propiônico com baixo ponto de fusão |
| CN111116794A (zh) * | 2019-12-20 | 2020-05-08 | 蚌埠市鑫晟新材料科技有限公司 | 一种中性造纸用聚合材料的制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5920230A (ja) * | 1982-07-19 | 1984-02-01 | チバ−ガイギ−・アクチエンゲゼルシヤフト | ピルプロフエン含有薬剤 |
| DE3440288A1 (de) * | 1984-11-05 | 1986-05-07 | Gergely, Gerhard, Dr.-Ing., Wien | Pharmazeutische zubereitung mit einem gehalt an mindestens einer schleimhautreizenden substanz oder dergleichen, insbesondere profen, sowie verfahren zu ihrer herstellung |
| CA1298290C (en) * | 1987-01-09 | 1992-03-31 | Herand M. Markarian | Solution ibuprofen complexes, compositions and processes for preparing the same |
| GB8724763D0 (en) * | 1987-10-22 | 1987-11-25 | Aps Research Ltd | Sustained-release formulations |
| GB8813682D0 (en) * | 1988-06-09 | 1988-07-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
| CH677606A5 (zh) * | 1988-07-12 | 1991-06-14 | Aesculapius Pharma Sa | |
| DE3838431A1 (de) * | 1988-11-12 | 1990-05-17 | Bayer Ag | Ibuprofen-brausezubereitungen |
| IT1227626B (it) * | 1988-11-28 | 1991-04-23 | Vectorpharma Int | Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione |
| US5019663A (en) * | 1989-04-03 | 1991-05-28 | Mobil Oil Corp. | Heat balanced paraffin upgrading with co-fed oxygenate |
| JPH02279631A (ja) * | 1989-04-18 | 1990-11-15 | Yamanouchi Pharmaceut Co Ltd | 薬物のシクロデキストリン包接体及びその製造法 |
| CA2009326C (en) * | 1989-05-09 | 1998-01-27 | Lawrence J. Daher | Aqueous granulation solution and a method of tablet granulation |
| CA2021548A1 (en) * | 1989-09-01 | 1991-03-02 | Ronald Nash Duvall | Effervescent cold or sinus allergy medicine composition having reduced sodium content |
| US5024997A (en) * | 1990-06-22 | 1991-06-18 | American Home Products Corporation | Palatable ibuprofen solutions |
| DE4027927A1 (de) * | 1990-09-04 | 1992-03-05 | Bayer Ag | Brausekomponente und verfahren zu ihrer herstellung |
| DE4038314A1 (de) * | 1990-11-30 | 1992-06-04 | Puetter Medice Chem Pharm | Komplexe des aktiven enantiomers des ibuprofens mit cyclodextrin |
| JP2579251B2 (ja) * | 1991-03-12 | 1997-02-05 | ロシェ・コンシューマー・ヘルス・（ワールドワイド）・リミテッド | 非発泡性イブプロフェン組成物 |
-
1993
- 1993-08-10 GB GB939316580A patent/GB9316580D0/en active Pending
-
1994
- 1994-07-29 EP EP94926129A patent/EP0720476A1/en not_active Withdrawn
- 1994-07-29 CA CA002169159A patent/CA2169159C/en not_active Expired - Fee Related
- 1994-07-29 JP JP7506202A patent/JPH09501421A/ja active Pending
- 1994-07-29 AU AU76099/94A patent/AU688789B2/en not_active Ceased
- 1994-07-29 WO PCT/EP1994/002515 patent/WO1995004528A2/en not_active Application Discontinuation
- 1994-07-29 CN CN94193729A patent/CN1112180C/zh not_active Expired - Fee Related
- 1994-08-08 ZA ZA945930A patent/ZA945930B/xx unknown
- 1994-08-11 TW TW083107332A patent/TW354256B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GB9316580D0 (en) | 1993-09-29 |
| EP0720476A1 (en) | 1996-07-10 |
| ZA945930B (en) | 1995-04-05 |
| CN1133006A (zh) | 1996-10-09 |
| WO1995004528A3 (en) | 1995-03-16 |
| CA2169159C (en) | 2005-01-25 |
| CN1112180C (zh) | 2003-06-25 |
| AU688789B2 (en) | 1998-03-19 |
| AU7609994A (en) | 1995-02-28 |
| JPH09501421A (ja) | 1997-02-10 |
| WO1995004528A2 (en) | 1995-02-16 |
| CA2169159A1 (en) | 1995-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW354256B (en) | A pharmaceutical composition for oral consumption in aqueous solution comprising a drug/<beta>-cyclodextrin complex and a pharmaceutically acceptable acid-base couple | |
| HK1050839A1 (en) | Use of pharmaceutical compositions comprising oxcarbazepine in the fasted state | |
| CA2086343A1 (en) | Sustained release thyroactive composition | |
| BR9805749A (pt) | Composição de ibuprofeno. | |
| IT1264855B1 (it) | Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici | |
| GEP20022784B (en) | Celecoxib Composition | |
| NZ508037A (en) | A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer | |
| WO1997003655A1 (en) | Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules | |
| ES2006649A6 (es) | Una composicion para depositarse sobre la superficie de un granulo de un producto farmaceutico y procedimiento para la obtencion de la misma. | |
| MX9801727A (es) | Composicion farmaceutica para administracion oral. | |
| CA2234426A1 (en) | Antibacterial composition for oral administration | |
| KR880010767A (ko) | 비스테로이드성 소염제를 함유하는 약제학적 제제 | |
| KR930009605A (ko) | 소염 또는 진통제 | |
| DE69415018T2 (de) | Oralanzuwendende flüssige arzneizubereitung enthaltend 2-(4-isobutylphenyl)propionsäure | |
| ATE73656T1 (de) | Entzuendungshemmendes ibuprofen enthaltendes arzneimittel, das in waessriger loesung keinen bitteren geschmack, keine reizung des kehlkopfes und keine intestinale toxizitaet aufweist. | |
| EP0208519A3 (en) | Solubilized composition of hardly-soluble pharmaceutical product | |
| ES2109131B1 (es) | Composicion farmaceutica que tiene actividad analgesica. | |
| NZ332655A (en) | Pharmaceutical compositions containing diclofenac and alkali metal bicarbonates | |
| MY108692A (en) | Topical composition | |
| DE69617868D1 (de) | Geschmacksmaskierte wässrige Lösungen enthaltend Ibuprofen und Menthol | |
| Schlesinger | Dietary fluorides and caries prevention | |
| Ranløv et al. | Faecal blood loss during administration of acetylsalicylic acid, ketoprofen and two new ketoprofen sustained-release compounds | |
| Cooke | Gastric emptying in the cat in response to hypertonic solutions and tryptophan | |
| JPS62126130A (ja) | 動物用医薬組成物 | |
| KANIWA et al. | The bioavailabilities of aspirin from an aspirin aluminum and an aspirin tablets and the effects of food and aluminum hydroxide gel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |